STAT+: Canada approves ALS drug from Amylyx Pharma as U.S. patients await extended review
Amylyx Pharmaceuticals secured approval in Canada on Monday for a new medicine to treat patients…
Author: STAT
Opinion: Understanding long Covid will take the lived experiences of long haulers
I went from training for the Big Sur 21-miler to barely being able to climb…
Listen: Diverse clinical trials: Why aren’t we there yet?
Clinical trials are critical to advancing lifesaving medications and treatments. But the U.S. is falling…
STAT+: Biotech is practically in San Diego’s DNA. Here’s how it got there — and how it might evolve
SAN DIEGO — More than 40 years ago, Ivor Royston, a brash young assistant professor…
.jpg)
STAT+: Simmering disputes persist as Covid patent waiver talks come down to the wire
On Sunday, the World Trade Organization will hold a long-delayed ministerial conference to craft a…
‘Discriminatory and stigmatizing’: Scientists push to rename monkeypox viruses
A group of scientists from Africa and elsewhere are urging the scientific community and world…
STAT+: Updated study results show a CRISPR treatment for blood diseases continues to benefit patients
Updated results announced Saturday from two clinical trials involving an experimental, genome-editing treatment showed prolonged…
STAT+: FDA advisers endorse Bluebird gene therapy for rare blood disorder
A panel of advisers to the Food and Drug Administration voted unanimously to recommend approval…
Opinion: Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity
When the history of the Covid-19 pandemic is written, readers will be as stunned by…
STAT+: Florida hospital system sues religious sharing ministry over unpaid medical claims
Orlando Health is suing Liberty HealthShare, a Christian health care sharing ministry, alleging Liberty owes…
STAT+: Pharmalittle: FDA panel endorses Bluebird Bio gene therapy for rare disease; GSK touts RSV vaccine trial results
And so, another working week will soon draw to a close. Not a moment too…
STAT+: GSK says RSV vaccine for older adults ‘offers exceptional protection’
GSK said Friday that its RSV vaccine showed “statistically significant and clinically meaningful efficacy” in…
Opinion: Pursuit of profits is driving drug companies to break the 340B law
Seventeen drug companies, including some of the world’s largest, are flouting a 30-year-old federal program…
Are these Cocoa Krispies-loving hamsters a key to cracking long Covid?
New York — In late 2020, Justin Frere, a wiry M.D./Ph.D. student dressed in head-to-toe…
FDA advisers unanimously endorse Bluebird’s gene therapy for rare disorder
Advisers to the Food and Drug Administration voted unanimously in favor of approving an investigational…
STAT+: With Cerner deal closed, Oracle chair pitches sweeping vision for health records and artificial intelligence
Oracle chairman and chief technology officer Larry Ellison vowed to prioritize the cloud giant’s health…
Listen: Applause-worthy cancer data, the long wait for Novavax, & the next FDA controversy
When is data “practice-changing”? How many Covid-19 vaccines do we need? And what does it…
STAT+: Pharmalittle: FDA decision on Novavax Covid shot could be delayed; new drug prices rose 20% annually in recent years
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: How high? Prices for newly launched medicines rose 20% annually, analysis finds
Talk about inflation Amid ongoing angst over prescription drug costs, a new analysis finds that…
Opinion: Wastewater monitoring: how to strengthen and sustain an important public health tool
Wastewater monitoring has gained visibility and credibility as an effective pandemic management tool. Yet despite…
How much medicine does the U.S. actually have to fight monkeypox?
WASHINGTON — As the world grapples with a monkeypox outbreak, the Biden administration has been quick…
STAT+: BioSpring Partners closes $245 million first fund as private markets tense up
When Michelle Dipp and Jennifer Lum decided to launch a life sciences growth equity fund…
STAT+: Pharmalittle: FDA panel endorses Novavax Covid shot; FTC to probe pharmacy benefit managers
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT+: FTC will investigate pharmacy benefit managers and their role in prescription drug costs
After months of deliberation, the U.S. Federal Trade Commission has voted unanimously to investigate several…
Moderna says Omicron-containing booster outperforms current vaccine
Moderna said Wednesday that using a new version of its Covid-19 vaccine as a booster…
Opinion: FDA user fee legislation needs to mitigate the pharmaceutical industry’s carbon pollution
As Congress works to reauthorize for the seventh time pharmaceutical user fee legislation, it is…
Opinion: STAT+: How the U.S. can mitigate and prevent medical device shortages
Just weeks after the U.S. declared Covid-19 to be a public health emergency in early…
Homeless and incarcerated people in Minnesota struggled to access Covid vaccines
Homeless and incarcerated people had significantly lower Covid vaccination rates than others in Minnesota, according…
How the hard lessons of the AIDS crisis are shaping the response to the monkeypox outbreak
As officials, researchers and activists scramble to control an emerging monkeypox outbreak, many are doing…
Opinion: A growing gap in premature deaths along party lines underscores the collision of politics and public health
In an ideal world, public health would be independent of politics. Yet recent events in…
FDA advisers recommend authorization of Novavax’s Covid-19 vaccine
Experts who advise the Food and Drug Administration voted overwhelmingly on Tuesday to recommend the…
Apple unveils a medication-tracking app and new heart health features for smartwatches
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Watch: An interview with the FDA’s top cancer regulator
On Friday, Richard Pazdur, the director of the FDA Oncology Center of Excellence, sat down…
STAT+: Study suggests a new harm from hospital mergers: less price transparency
Health care economists argue hospital mergers can raise costs and lower quality. And now, a…
STAT+: Pharmalittle: FDA panel will scrutinize Novavax shot for Covid-19; J&J and Emergent accuse each other of breach
Top of the morning to you, and a fine one it is. Blue skies and…
STAT+: Former Lilly manager files whistleblower lawsuit over manufacturing failures at production plant
A former Eli Lilly human resources officer sued the drug company after claiming she lost…
STAT+: A dose of transparency by Cel-Sci does nothing to burnish its failed cancer immunotherapy
CHICAGO — I met Cel-Sci CEO Geert Kersten for the first time on Monday at…
Opinion: It’s time to move past Aduhelm and focus on a broader Alzheimer’s drug pipeline
When Alzheimer’s disease was believed to be caused solely by the accumulation of amyloid protein…
STAT+: ‘All about strengthening health systems’: New coalition pushes to license cancer drugs to low-income countries
Over the past two decades, public health officials and patient advocacy groups have pushed the…
‘Testing bottleneck’ for monkeypox puts hope of containment at risk, experts warn
Infectious disease specialists are growing increasingly concerned by the U.S. strategy for testing for monkeypox,…
STAT+: The graveyard of health tech pilots: why some experiments flourish and others fizzle
Pilot programs are health tech’s proving ground: they let health systems test-drive new devices and…
Survey finds many Black cancer patients would consider clinical trials but aren’t offered the chance
CHICAGO — Nobody offered Stephanie Walker a clinical trial when she was diagnosed with metastatic…
STAT+: Pharmalittle: Cancer drug trial yields remission in every patient; Novartis data hacked by extortionists
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Praxis’ novel antidepressant fails make-or-break trial
A novel antidepressant from Praxis Precision Medicines failed to outperform placebo in a pivotal study,…
STAT+: Adicet ‘gamma-delta’ T cell therapy shows complete remissions in early study of lymphoma patients
CHICAGO — Adicet Bio reported Monday that a unique, off-the-shelf therapy made from a special…
Opinion: ‘Pink tape’ at the FDA is delaying access to contraception — again
As the crisis over access to reproductive health deepens in the U.S., the Food and…
STAT+: With new research, health tech companies try to make a case for virtual diabetes care
For all the time and money health tech companies have poured into developing virtual care…
If Roe is overturned, the ripples could affect IVF and genetic testing of embryos, experts warn
Through their foundation, Allie LaForce and Joe Smith have so far helped families have 17…
With the right molecular signal, a cancer drug works in every patient
Sascha Roth was in her late 30s and feeling great. Then she noticed some bleeding…
STAT+: Roche’s Tigit troubles escalate, sparking more debate about the closely tracked cancer immunotherapy target
CHICAGO — Roche had previously announced the failure of its closely tracked anti-TIGIT immunotherapy in…